AYTU BIOPHARMA, INC (AYTU) › Net IncomeAYTU BIOPHARMA, INC (AYTU) — Net IncomeAnnual figures by fiscal year, from SEC filings.2006: -$70.4K2007: -$49.0K2008: -$57.2K2009: -$58.9K2010: -$60.3K2011: -$136.8K2012: -$59.7K2014: -$5.58M2015: -$7.72M2016: -$28.18M2017: -$22.51M2018: -$10.19M2019: -$27.13M2020: -$13.62M2021: -$58.29M2022: -$108.78M2023: -$17.05M2024: -$15.84M2025: -$13.56M-$13.56M2006Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$13.56M+14.4%2024-$15.84M+7.1%2023-$17.05M+84.3%2022-$108.78M-86.6%2021-$58.29M-327.9%2020-$13.62M+49.8%2019-$27.13M-166.3%2018-$10.19M+54.7%2017-$22.51M+20.1%2016-$28.18M-264.9%2015-$7.72M-38.4%2014-$5.58M—2012-$59.7K+56.4%2011-$136.8K-127.0%2010-$60.3K-2.3%2009-$58.9K-3.0%2008-$57.2K-16.8%2007-$49.0K+30.5%2006-$70.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share